Wendy future of retail top

Michael Ullmann

Johnson & Johnson to appeal “flawed” opioid judgment in Oklahoma

Johnson & Johnson to appeal “flawed” opioid judgment in Oklahoma

NEW BRUNSWICK, N.J. – Johnson & Johnson and its Janssen Pharmaceutical Cos. announced they will appeal the $572 million civil judgment entered in Cleveland County District Court in the State of Oklahoma’s lawsuit against opioid manufacturers. The company is confident it has strong grounds to appeal this decision. The judgment disregards the Company’s compliance with

PP_1170x120_10-25-21